Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Frontera Therapeutics Begins Trials for Three Leading Gene Therapy Candidates

publication date: Feb 17, 2023

Frontera Therapeutics, a US-China gene therapy company, has begun China trials of its three leading candidates – all starting in the first two months of 2023. The company’s APEX Technology & Manufacturing Platform is an adeno-associated virus (AAV) gene expression system based on novel and clinically validated AAV vectors. The trials include FT-002 for X-linked retinitis pigmentosa (XLRP); FT-003 for neovascular or wet age-related macular degeneration (wAMD); and FT-001 for Leber Congenital Amaurosis-2, an inherited retinal disease. Frontera is headquartered in the Boston area with labs and a manufacturing facility in Suzhou. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here